Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events | Zendy

Nathan D. Wong | Zendy; Heidi Gransar | Zendy; Jagat Narula | Zendy; Leslee J. Shaw | Zendy; Johanna H. Moon | Zendy; Romalisa Miranda-Peats | Zendy; Alan Rozanski | Zendy; Sean W. Hayes | Zendy; Louise Thomson | Zendy; John D. Friedman | Zendy; Daniel S. Berman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events

Author(s) -

Nathan D. Wong,

Heidi Gransar,

Jagat Narula,

Leslee J. Shaw,

Johanna H. Moon,

Romalisa Miranda-Peats,

Alan Rozanski,

Sean W. Hayes,

Louise Thomson,

John D. Friedman,

Daniel S. Berman

Publication year - 2009

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2009.05.012

Subject(s) - medicine , asymptomatic , myeloperoxidase , hazard ratio , subclinical infection , cardiology , body mass index , blood pressure , confidence interval , gastroenterology , incidence (geometry) , inflammation , physics , optics

We evaluated whether myeloperoxidase (MPO) predicts future cardiovascular disease (CVD) events in asymptomatic adults and whether subclinical atherosclerosis may affect this relation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research